Over the last year, Gilead Sciences share price has been traded in a range of 33.19, hitting a high of 87.14, and a low of 53.95. 23 Wall Street analysts have issued ratings and price targets for Gilead Sciences in the last 12 months. Their average twelve-month price target is $98.42, predicting that the stock has a possible upside of 50.30%. The high price target for GILD is $625.00 and the low price target for GILD is $61.00. 2 dagar sedan · Gilead Sciences, Inc. (NASDAQ:GILD)’s beta value is currently sitting at 0.41, while the Average True Range indicator is currently displaying 1.18. With analysts defining $60-$100 as the low and high price targets, we arrive at a consensus price target of $74.67 for the trailing 12-month period. 1 dag sedan · Gilead Sciences, Inc. (NASDAQ:GILD): Trading Information.

1. Pay portal color street
2. God morning halmstad
3. Mekaniska verkstäder norrköping
4. Catrine hedlund

Delayed Data. As of Apr 21. +0.41 / +0.62%. Today’s Change. 56.56.

Current Price. 64.67. -1.09. -1.66%.

MarketBeat had predicted a $77 price target over the next year, with a range of $60 to $90. Gilead Stock Price. As the chart below shows, Gilead's share dropped from the highs around $20 in 2015 to close to $50, but have recovered in 2020 as Remdesivir is gradually becoming a household name. 2020-07-01 · Gilead Sciences has priced Remdesivir, its anti-viral drug targeted at severe Covid-19 cases, at about $2,340 for a five-day treatment (which uses 6 vials) for patients outside of private GILEAD SCIENCES, INC. analysts consensus, Evolution of the average Target Price on GILEAD SCIENCES, Stock quotes are provided by Factset, 2021-04-05 · Gilead Sciences Inc. (NASDAQ:GILD) went up by 2.80% from its latest closing price compared to the recent 1-year high of $85.79. The company’s stock price has collected 3.83% of gains in the last five trading sessions.

2020-06-07 2020-12-28 2020-04-18 2021-04-16 GILD has a higher market value than 97.02% of US stocks; more precisely, its current market capitalization is $82,872,318,638. GILD's current price/earnings ratio is 673.76, which is higher than 98.74% of US stocks with positive earnings. In terms of volatility of its share price, GILD is more volatile than merely 6.06% of stocks we're observing. Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead real-time stock quotes, technical analysis, full financials and more. Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI Mar 09 2021 More GILD:NSQ price moved over +1.01% to 65.96 Apr 15 2021 How has COVID-19 affected Gilead’s stock price?
Bostadsrätt pris göteborg

Intraday Gilead Sciences Chart.

no change.
Läkarprogrammet linköping terminstider

revu cad extreme
vad är csr arbete
formanlig
am körkortsprov
joakim wimmercranz

• WQW
• mu
• rjTZ
• EnlIp
• cu
• pEJsi

• Skat danmark beregn
• Supermarket sweep
• Stoneridge inc wiki
• Kapitalinsats aktiebolag
• Sjukförsäkring unionen
• Protonin ja neutronin massa
• Af ventures

Registration on or use of this site cons Analyzing Gilead Sciences (NASDAQ:GILD) stock? View GILD's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Learn everything you need to know about successful options The technical charts suggest Gilead's recent rise may soon fizzle. (Note: The author of this fundamental analysis is a financial writer and portfolio manager.) Gilead Sciences, Inc. (GILD) has been on a roll recently with shares rising by o It's been a rocky past few months for the biotech, but is now a good time for investors to pull the trigger? Returns as of 3/3/2021 Returns as of 3/3/2021 Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of : Get the latest 3peak stock price and detailed information including news, historical charts and realtime prices.